Beijing Tongrentang Co Ltd
SSE:600085
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
30.4
38.24
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Beijing Tongrentang Co Ltd
SSE:600085
|
41.8B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
529.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
269.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.8B USD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Beijing Tongrentang Co Ltd
Glance View
Nestled in the heart of Beijing's bustling historic district, Beijing Tongrentang Co. Ltd. trace their origins back to 1669 during the Qing Dynasty. This venerable institution has often been heralded as the steward of traditional Chinese medicine (TCM), expertly bridging over three centuries of heritage with the demands of modern healthcare. The company's deep-rooted ethos is centered on the enduring principles of TCM, which emphasize balance and holistic well-being, a philosophy that they have meticulously preserved and adapted over generations. The intricate potions, herbal remedies, and elaborate tonics they craft are derived from a unique blend of ancient recipes and rigorous quality standards, ensuring both authenticity and efficacy. This reverence for tradition, coupled with a commitment to innovation, underpin the strength and credibility of Tongrentang's brand, allowing it to not only maintain but also expand its standing globally. From the cobblestones of Beijing, Tongrentang's operations today encompass a sophisticated network of production facilities, retail outlets, and strategic partnerships, turning the company into a formidable player in the health sector. While steeped in history, this hallmark of traditional Chinese medicine makes its earnings through a modern business model that includes pharmaceuticals, healthcare services, and retail. Their production capabilities boast advanced manufacturing technologies that complement their traditional processes, ensuring scalable and efficient operations without compromising the character of their products. Retail remains a core avenue, with a vast array of stores in China and abroad that serve as conduits for both commerce and education, introducing new generations to TCM. Additionally, Tongrentang has successfully ventured into healthcare services, with clinics providing wellness treatments and consultations that encapsulate the essence of their medicinal philosophy, thus diversifying income streams while deepening consumer engagement with its storied brand.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Beijing Tongrentang Co Ltd is 12.6%, which is below its 3-year median of 16.1%.
Over the last 3 years, Beijing Tongrentang Co Ltd’s Operating Margin has decreased from 16.4% to 12.6%. During this period, it reached a low of 12.6% on Oct 30, 2025 and a high of 18.8% on Sep 30, 2023.